CDR-Life AG ^None

CDR-Life AG is a biotech company based in Zurich, Switzerland that focuses on developing therapeutic antibody fragments for immuno-oncology and ophthalmology. Their facilities are located in the Bio-Technopark in Schlieren-Zurich. The company is developing specific antibody therapeutics to target intracellular proteins presented on the major histocompatibility complex (MHC) to create a pipeline of first-in-class therapeutics for a broad range of solid tumors.